GLP-1 Physiology Beyond the Pancreas
GLP-1 receptors throughout the body create effects far beyond blood sugar control.
GLP-1 receptors throughout the body create effects far beyond blood sugar control.
The two hormones work in opposing directions to stabilize blood sugar.
Why DPP-4 enzyme destruction forced all GLP-1 drug designs.
cAMP amplification explains why GLP-1 drugs pose minimal hypoglycemia risk.
Nanoparticles could protect peptides from degradation and enable intranasal delivery.
New imaging study confirms insulin reaches the brain via nasal delivery in humans.
Enzymes, mucus, tight junctions, and efflux pumps make oral peptide absorption nearly impossible.
Nausea strikes nearly one in four GLP-1 patients through distinct brain and gut pathways.
GLP-1 receptors throughout the brain may protect against addiction and cognitive decline.
Most GLP-1 patients quit within a year, largely due to weak feedback loops.
Two nasal pathways to the brain work differently and require distinct drug targeting strategies.